From the genetic architecture to synaptic plasticity in autism spectrum disorder
The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Abstract
Genetics studies of autism spectrum disorder (ASD) have identified several risk genes that are key regulators of synaptic plasticity. Indeed, many of the risk genes that have been linked to these disorders encode synaptic scaffolding proteins, receptors, cell adhesion molecules or proteins that are involved in chromatin remodelling, transcription, protein synthesis or degradation, or actin cytoskeleton dynamics. Changes in any of these proteins can increase or decrease synaptic strength or number and, ultimately, neuronal connectivity in the brain. In addition, when deleterious mutations occur, inefficient genetic buffering and impaired synaptic homeostasis may increase an individual's risk for ASD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Social relationships, which appear altered in autism and autism spectrum disorder, are thought to affect the GNW architectures for conscious processing (Bourgeron, 2015; Graziano and Kast-ner, 2011).”
From Conscious Processing and the Global Neuronal Workspace Hypothesis (2020) · cites this paper as Bourgeron, 2015
In the citing paper
“Emerging evidence has suggested that both ASD and dyslexia have strong genetic components in their etiologies that involve multigene interaction (Raskind et al., 2012; Bourgeron, 2015).”
From Two Autism/Dyslexia Linked Variations of DOCK4 Disrupt the Gene Function on Rac1/Rap1 Activation, Neurite Outgrowth, and Synapse Development (2020) · cites this paper as Bourgeron, 2015
In the citing paper
“Despite heterogeneous origins, emerging genetic and pathological findings point to a conclusion that ASD is a disease with impaired neuronal connectivity (Bourgeron, 2015).”
From Two Autism/Dyslexia Linked Variations of DOCK4 Disrupt the Gene Function on Rac1/Rap1 Activation, Neurite Outgrowth, and Synapse Development (2020) · cites this paper as Bourgeron, 2015
In the citing paper
“ASD exhibits a strong genetic basis, and increasing evidence from inherited and de novo gene variations suggests a notable convergence on synapse pathophysiology in ASD, particularly dysfunction of excitatory synaptic transmission 1, 2.”
From Autism-like social deficit generated by Dock4 deficiency is rescued by restoration of Rac1 activity and NMDA receptor function. (2021) · cites this paper as [1]
In the citing paper
“collectively, these genetic factors are involved in the etiology of only ~20% of ASD cases17,18.”
From Genome-wide detection of tandem DNA repeats that are expanded in autism (2020) · cites this paper as [17]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1943) · The Nervous child · Cited by 8,870
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Synaptic, transcriptional and chromatin genes disrupted in autism
Study, T. D., De Rubeis, S., Autism, H. M. C. F., UK10K Consortium, The Autism Sequencing Consortium, He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Ercument Cicek, A., et al. (2014) · Nature · doi:10.1038/nature13772 · Cited by 2,746
Global Prevalence of Autism and Other Pervasive Developmental Disorders
Elsabbagh, M., Divan, G., Koh, Y., Kim, Y. S., Kauchali, S., Marcín, C., Montiel‐Nava, C., Patel, V., Paula, C. S., Wang, C., et al. (2012) · Autism Research · doi:10.1002/aur.239 · Cited by 2,636
The contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
Activity-dependent scaling of quantal amplitude in neocortical neurons
Turrigiano, G. G., Leslie, K. R., Desai, N. S., Rutherford, L. C., & Nelson, S. B. (1998) · Nature · doi:10.1038/36103 · Cited by 2,480
Research works printed but not linked: 1
- Coleman, M. & Gillberg, C. The Autisms 4th edn (Oxford University Press, 2012).
Cited by
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Bishop, D. V. M., Snowling, M. J., Thompson, P. A., Greenhalgh, T., & and the CATALISE‐2 consortium (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12721 · Cited by 1,641
“…genetic or neurological causes (Fitzgerald et al., 2015; Shevell, Majnemer, Rosenbaum, & Abrahamowicz, 2001), with the numbers of known aetiology increasing with advances in genetic methods (Bourgeron, 2015; Fitzgerald et al., 2015; Shevell et al., 2001).”
Conscious Processing and the Global Neuronal Workspace Hypothesis
Mashour, G. A., Roelfsema, P., Changeux, J.-P., & Dehaene, S. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.026 · Cited by 1,164
“Social relationships, which appear altered in autism and autism spectrum disorder, are thought to affect the GNW architectures for conscious processing (Bourgeron, 2015; Graziano and Kastner, 2011).”
BackgroundRobertson, C. E., & Baron-Cohen, S. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.112 · Cited by 1,157
The Changing Epidemiology of Autism Spectrum Disorders
Lyall, K., Croen, L., Daniels, J., Fallin, M. D., Ladd-Acosta, C., Lee, B. K., Park, B. Y., Snyder, N. W., Schendel, D., Volk, H., et al. (2017) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031816-044318 · Cited by 1,011
“Over the past decade, genetic studies have been quite successful at identifying rare genetic variation, including inherited and de novo mutations and copy number variations (CNVs), related to autism or autistic features (18).”
BackgroundSohal, V. S., & Rubenstein, J. L. R. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0426-0 · Cited by 988
An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options
Masi, A., DeMayo, M. M., Glozier, N., & Guastella, A. J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0100-y · Cited by 987
“The genetic architecture in ASD varies substantially, from a single penetrant mutation being enough to cause ASD, to an accumulation of over one thousand low-risk alleles [57].”
BackgroundSynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
Koopmans, F., van Nierop, P., Andres-Alonso, M., Byrnes, A., Cijsouw, T., Coba, M. P., Cornelisse, L. N., Farrell, R. J., Goldschmidt, H. L., Howrigan, D. P., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.002 · Cited by 938
“, 2010; Bourgeron, 2015; Grant, 2012; Monday and Castillo, 2017), such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), schizophrenia, Alzheimer’s disease, and Parkinson’s disease (Arnsten et al., 2012; Bourgeron, 2015; De Rubeis et al., 2014; Fromer et al., 2014; Heutink and Verhage…”
BackgroundInfluentialWhole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
C Yuen, R. K., Merico, D., Bookman, M., L Howe, J., Thiruvahindrapuram, B., Patel, R. V., Whitney, J., Deflaux, N., Bingham, J., Wang, Z., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4524 · Cited by 844
“putative de novo SNVs from the Illumina WGS data of two probands (2-1266-003 and 3-0141-000) in the trio families and from Complete Genomics WGS data of one proband (2-1292-003) in a quartet family for Sanger sequencing ( Supplementary Table 3 ).”
InfluentialEnhancing studies of the connectome in autism using the autism brain imaging data exchange II
Di Martino, A., O’Connor, D., Chen, B., Alaerts, K., Anderson, J. S., Assaf, M., Balsters, J. H., Baxter, L., Beggiato, A., Bernaerts, S., et al. (2017) · Scientific Data · doi:10.1038/sdata.2017.10 · Cited by 710
Neurodevelopmental Disorders: From Genetics to Functional Pathways
Parenti, I., Rabaneda, L. G., Schoen, H., & Novarino, G. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.05.004 · Cited by 618
“Accordingly, a detailed description of behavioral phenotypes is currently available for numerous haploinsufficient mouse models [89].”
BackgroundThe Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium (2017) · Molecular Autism · doi:10.1186/s13229-017-0137-9 · Cited by 587
“Genetic insult which disrupts the synapse as a model of ASD is not novel [60], with genes encoding members of the SHANK, neurexin and neuroligin families, all well established as risk factors for ASD.”
BackgroundGreven, C. U., Lionetti, F., Booth, C., Aron, E. N., Fox, E., Schendan, H. E., Pluess, M., Bruining, H., Acevedo, B., Bijttebier, P., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.01.009 · Cited by 491
Atypical functional connectome hierarchy in autism
Hong, S.-J., Vos de Wael, R., Bethlehem, R. A. I., Lariviere, S., Paquola, C., Valk, S. L., Milham, M. P., Di Martino, A., Margulies, D. S., Smallwood, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08944-1 · Cited by 531
A Single-Cell Transcriptomic Atlas of Human Neocortical Development during Mid-gestation
Polioudakis, D., de la Torre-Ubieta, L., Langerman, J., Elkins, A. G., Shi, X., Stein, J. L., Vuong, C. K., Nichterwitz, S., Gevorgian, M., Opland, C. K., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.011 · Cited by 513
Mechanisms governing activity-dependent synaptic pruning in the developing mammalian CNS
Faust, T. E., Gunner, G., & Schafer, D. P. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00507-y · Cited by 437
Autism genes converge on asynchronous development of shared neuron classes
Paulsen, B., Velasco, S., Kedaigle, A. J., Pigoni, M., Quadrato, G., Deo, A. J., Adiconis, X., Uzquiano, A., Sartore, R., Yang, S. M., et al. (2022) · Nature · doi:10.1038/s41586-021-04358-6 · Cited by 439
Livingston, L. A., & Happé, F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.005 · Cited by 414
Epigenetic Regulation in Neurodegenerative Diseases
Berson, A., Nativio, R., Berger, S. L., & Bonini, N. M. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.05.005 · Cited by 387
Howes, O. D., Rogdaki, M., Findon, J. L., Wichers, R. H., Charman, T., King, B. H., Loth, E., McAlonan, G. M., McCracken, J. T., Parr, J. R., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117741766 · Cited by 342
“Specific examples include the N-methyl-D-aspartate (NMDA) 2B glutamate ionotropic and gamma-aminobutyric acid (GABA) receptors (including GABARA3 and GABARB3), cell adhesion molecules, scaffolding proteins such as SHANK1, SHANK2, SHANK3 ankyrin repeat domain proteins (Bourgeron, 2015), and neuron-glia signalling and m…”
Kochinke, K., Zweier, C., Nijhof, B., Fenckova, M., Cizek, P., Honti, F., Keerthikumar, S., Oortveld, M. A. W., Kleefstra, T., Kramer, J. M., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.11.024 · Cited by 322
A synaptic perspective of fragile X syndrome and autism spectrum Disorders.
Bagni, C., & Zukin, R. S. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.041 · Cited by 326
“Human neuropathological and genetic findings on model systems suggest that FXS and ASDs may be conceptualized as diseases of the synapse because of the aberrant dendritic spine morphology and density (Bourgeron, 2015; Zoghbi and Bear, 2012).”
BackgroundInfluentialHistone Acetylome-wide Association Study of Autism Spectrum Disorder
Sun, W., Poschmann, J., Cruz-Herrera del Rosario, R., Parikshak, N. N., Hajan, H. S., Kumar, V., Ramasamy, R., Belgard, T. G., Elanggovan, B., Wong, C. C. Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.031 · Cited by 306
“Among loci with increased H3K27ac, there was strong enrichment for genes related to ion channels, synaptic function, and epilepsy/ neuronal excitability, all of which have previously been shown to be dysregulated in this disorder (Voineagu et al., 2011; Bourgeron, 2015).”
Assessing the human health risks of perfluorooctane sulfonate by in vivo and in vitro studies
Zeng, Z., Song, B., Xiao, R., Zeng, G., Gong, J., Chen, M., Xu, P., Zhang, P., Shen, M., & Yi, H. (2019) · Environment International · doi:10.1016/j.envint.2019.03.002 · Cited by 299
Lessons learned from studying syndromic autism spectrum disorders
Sztainberg, Y., & Zoghbi, H. Y. (2016) · Nature Neuroscience · doi:10.1038/nn.4420 · Cited by 281
Loth, E., Charman, T., Mason, L., Tillmann, J., Jones, E. J. H., Wooldridge, C., Ahmad, J., Auyeung, B., Brogna, C., Ambrosino, S., et al. (2017) · Molecular Autism · doi:10.1186/s13229-017-0146-8 · Cited by 299
“Likewise, hundreds of common and rare risk genes have been identified [7].”
Self-citationSignalling pathways in autism spectrum disorder: mechanisms and therapeutic implications
Jiang, C.-C., Lin, L.-S., Long, S., Ke, X.-Y., Fukunaga, K., Lu, Y.-M., & Han, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01081-0 · Cited by 258
“4).(74,175) Therefore, abnormalities in synaptic proteins might be some of the mechanisms that increase the risk of developing ASD.”
BackgroundCheroni, C., Caporale, N., & Testa, G. (2020) · Molecular Autism · doi:10.1186/s13229-020-00370-1 · Cited by 256
“Regarding synaptic functionality, affected genes are retrieved among key players of both glutamatergic and GABAergic transmission as well as scaffolding proteins such as those belonging to the SHANK family and neurexin cell adhesion molecules [10, 28, 34].”
BackgroundGenetics and epigenetics of autism spectrum disorder—current evidence in the field
Wiśniowiecka-Kowalnik, B., & Nowakowska, B. A. (2019) · Journal of Applied Genetics · doi:10.1007/s13353-018-00480-w · Cited by 231
“Despite of the identified hundreds of loci involved in ASD, the genetic variants classified as etiological factors are identified only in about 25–35% of the cases (Schaefer et al. 2013; Bourgeron 2015).”
BackgroundDendritic Spine Plasticity: Function and Mechanisms
Runge, K., Cardoso, C., & de Chevigny, A. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00036 · Cited by 231
“Some of the best-studied syndromic ASD genes are FMR1 (Fragile X syndrome), TSC (Tuberous sclerosis), and UBE3a (Angelman syndrome; Bourgeron, 2015; Sztainberg and Zoghbi, 2016).”
BackgroundSpratt, P. W. E., Ben-Shalom, R., Keeshen, C. M., Burke, K. J., Clarkson, R. L., Sanders, S. J., & Bender, K. J. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.037 · Cited by 244
“Excitatory Synapses Are Impaired in Mature Scn2a Neurons Impairments of both axonal and dendritic excitability could affect synapses, which are a common locus of dysfunction in mouse models with ASD-associated genetic variants (Bourgeron, 2015; Monteiro and Feng, 2017; Tsai et al., 2012).”
BackgroundGenome-wide detection of tandem DNA repeats that are expanded in autism
Trost, B., Engchuan, W., Nguyen, C. M., Thiruvahindrapuram, B., Dolzhenko, E., Backstrom, I., Mirceta, M., Mojarad, B. A., Yin, Y., Dov, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2579-z · Cited by 238
Raghavan, R., Riley, A. W., Volk, H., Caruso, D., Hironaka, L., Sices, L., Hong, X., Wang, G., Ji, Y., Brucato, M., et al. (2018) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12414 · Cited by 233
Dysfunctional cerebellar Purkinje cells contribute to autism-like behaviour in Shank2-deficient mice
Peter, S., ten Brinke, M. M., Stedehouder, J., Reinelt, C. M., Wu, B., Zhou, H., Zhou, K., Boele, H.-J., Kushner, S. A., Lee, M. G., et al. (2016) · Nature Communications · doi:10.1038/ncomms12627 · Cited by 224
Genome-wide characteristics of de novo mutations in autism
Yuen, R. K., Merico, D., Cao, H., Pellecchia, G., Alipanahi, B., Thiruvahindrapuram, B., Tong, X., Sun, Y., Cao, D., Zhang, T., et al. (2016) · npj Genomic Medicine · doi:10.1038/npjgenmed.2016.27 · Cited by 216
Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders
Tabouy, L., Getselter, D., Ziv, O., Karpuj, M., Tabouy, T., Lukic, I., Maayouf, R., Werbner, N., Ben-Amram, H., Nuriel-Ohayon, M., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.015 · Cited by 214
“Some of these genes encode proteins that are related to synaptic transmission (Bourgeron, 2015), while others are related to epigenetic regulation (Loke et al., 2015).”
BackgroundNeurodiversity Studies: A New Critical Paradigm
(2020) · doi:10.4324/9780429322297 · Cited by 211
Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder
Wu, Y. E., Parikshak, N. N., Belgard, T. G., & Geschwind, D. H. (2016) · Nature Neuroscience · doi:10.1038/nn.4373 · Cited by 195
“The background gene lists were defined as follows: (1) for the strongest targets of differentially expressed miRNAs and ASD-associated miRNA modules, the intersection between (a) protein-coding genes expressed in the cortex and (b) the targets of all 699 miRNAs that are hit by two or more miRNAs and have a summed cont…”
BackgroundMethodInfluentialProgress in the genetics of autism spectrum disorder
Woodbury‐Smith, M., & Scherer, S. W. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13717 · Cited by 179
“Individuals harbour in the region of 3 million genetic variants, 95 per cent of which are shared with 5 per cent or more of the population and are termed ‘common variants’, 4 per cent are shared with between 1 per cent and 4 per cent of the population, and 1 per cent of which are rare or unique to any one individual o…”
BackgroundRomero-Garcia, R., Warrier, V., Bullmore, E. T., Baron-Cohen, S., & Bethlehem, R. A. I. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0023-7 · Cited by 188
“for autism risk are regulated by synaptic activity, leading to the hypothesis that dysregulation in synaptic homeostasis is a major risk for autism [55].”
BackgroundThe EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation
Charman, T., Loth, E., Tillmann, J., Crawley, D., Wooldridge, C., Goyard, D., Ahmad, J., Auyeung, B., Ambrosino, S., Banaschewski, T., et al. (2017) · Molecular Autism · doi:10.1186/s13229-017-0145-9 · Cited by 183
“Similarly, some rare genetic variants found in a small percentage of individuals are highly penetrant for ASD (i.e. copy number variants, single nucleotide variants) but also affect a diverse set of biological pathways [12 – 14].”
Self-citationTye, C., Runicles, A. K., Whitehouse, A. J. O., & Alvares, G. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00751 · Cited by 177
“Many of the core cognitive and behavioral symptoms associated with ASD are thought to arise from dysfunction of the central nervous system (3).”
Wnt signaling networks in autism spectrum disorder and intellectual disability
Kwan, V., Unda, B. K., & Singh, K. K. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9176-3 · Cited by 170
Behavioral neuroscience of autism
Takumi, T., Tamada, K., Hatanaka, F., Nakai, N., & Bolton, P. F. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.012 · Cited by 158
Shaping Synapses by the Neural Extracellular Matrix
Ferrer-Ferrer, M., & Dityatev, A. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00040 · Cited by 169
“Mutations in cerebellins and their presynaptic neurexin receptors have been associated with multiple neurodevelopmental disorders, especially with autism spectrum disorders (ASDs), Tourette syndrome and schizophrenia (Südhof, 2008; Clarke et al., 2012; Bourgeron, 2015; Pendyala et al., 2017).”
BackgroundFernandez, B. A., & Scherer, S. W. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.4/sscherer · Cited by 158
The landscape of DNA methylation amid a perfect storm of autism aetiologies
Ciernia, A. V., & LaSalle, J. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.41 · Cited by 165
Dhamne, S. C., Silverman, J. L., Super, C. E., Lammers, S. H. T., Hameed, M. Q., Modi, M. E., Copping, N. A., Pride, M. C., Smith, D. G., Rotenberg, A., et al. (2017) · Molecular Autism · doi:10.1186/s13229-017-0142-z · Cited by 171
Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167
“Thus, genetic factors contribute substantially and likely combine with environmental effects to guide clinical outcome (Bourgeron, 2015).”
InfluentialAutism spectrum disorder: insights into convergent mechanisms from transcriptomics
Quesnel-Vallières, M., Weatheritt, R. J., Cordes, S. P., & Blencowe, B. J. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0066-2 · Cited by 162
Simola, N., & Granon, S. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.008 · Cited by 157
Current knowledge on the genetics of autism and propositions for future research
Bourgeron, T. (2016) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2016.05.004 · Cited by 149
“The genetic landscape of ASD is therefore shaped by a complex interplay between common and rare variants and is most likely different from one individual to another [6].”
BackgroundSelf-citationMetabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches
Cheng, N., Rho, J. M., & Masino, S. A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00034 · Cited by 145
“…remodeling, protein translation and modification, neuroimmunological modulation, and mitochondrial function (Veenstra-Vanderweele et al., 2004; Bourgeron, 2015; De Rubeis and Buxbaum, 2015; Kopp et al., 2015; Loke et al., 2015; Mahfouz et al., 2015; Nelson and Valakh, 2015; Subramanian et…”
BackgroundSexually dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice
Jung, H., Park, H., Choi, Y., Kang, H., Lee, E., Kweon, H., Roh, J. D., Ellegood, J., Choi, W., Kang, J., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0208-z · Cited by 157
Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in mice
Wang, Q., Kong, Y., Wu, D., Liu, J., Jie, W., You, Q.-L., Huang, L., Hu, J., Chu, H.-D., Gao, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23843-0 · Cited by 168
Dorninger, F., Forss-Petter, S., Wimmer, I., & Berger, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105061 · Cited by 139
Fetit, R., Hillary, R. F., Price, D. J., & Lawrie, S. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.014 · Cited by 148
Deneault, E., White, S. H., Rodrigues, D. C., Ross, P. J., Faheem, M., Zaslavsky, K., Wang, Z., Alexandrova, R., Pellecchia, G., Wei, W., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.003 · Cited by 145
“Genetically-identified ASD risk genes are enriched in broader functional groups consisting of synapse function, RNA processing, and transcriptional regulation (Bourgeron, 2015; De Rubeis et al., 2014; Geschwind and State, 2015; Pinto et al., 2014; Yuen et al., 2017; Yuen et al., 2016).”
BackgroundLeblond, C. S., Le, T.-L., Malesys, S., Cliquet, F., Tabet, A.-C., Delorme, R., Rolland, T., & Bourgeron, T. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103623 · Cited by 136
“In some cases, one single de novo mutation can be causative whereas in other cases, a complex interplay between rare and frequent genetic variants increases the risk of developing a NDD (Bourgeron, 2015).”
BackgroundSelf-citationNeocortical neurogenesis and the etiology of autism spectrum disorder
Packer, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.002 · Cited by 138
Grova, N., Schroeder, H., Olivier, J. L., & Turner, J. D. (2019) · International Journal of Genomics · doi:10.1155/2019/2085496 · Cited by 158
Dynamics of social representation in the mouse prefrontal cortex
Levy, D. R., Tamir, T., Kaufman, M., Parabucki, A., Weissbrod, A., Schneidman, E., & Yizhar, O. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0531-z · Cited by 141
Autism and Cancer Share Risk Genes, Pathways, and Drug Targets
Crawley, J. N., Heyer, W.-D., & LaSalle, J. M. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.01.001 · Cited by 134
“Extraordinarily high heritability for autism spectrum disorder (ASD) has been detected in twin studies, with a range of 50–90% concordance between monozygotic twins, compared with 0–30% between dizygotic twins and siblings, and approximately 1% prevalence in the general population, along with a high male:female ratio…”
Autism spectrum disorders: an updated guide for genetic counseling
Griesi‐Oliveira, K., & Sertie, A. L. (2017) · Einstein (São Paulo) · doi:10.1590/s1679-45082017rb4020 · Cited by 262
“Although chromosomal microarray analysis and next generation sequencing technologies − which have enabled the high throughput screening of the genome − have greatly improved the diagnostic yield for ASD, variants that can be assigned as the etiological factors can be identified only in around 25% of the patients.(16)…”
BackgroundInfluentialSuetterlin, P., Hurley, S., Mohan, C., Riegman, K. L. H., Pagani, M., Caruso, A., Ellegood, J., Galbusera, A., Crespo-Enriquez, I., Michetti, C., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy058 · Cited by 131
PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases
Cai, Z., Li, S., Matuskey, D., Nabulsi, N., & Huang, Y. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.07.038 · Cited by 131
“dynamics or synaptic transmission [11].”
Postsynaptic density proteins and their involvement in neurodevelopmental disorders
Kaizuka, T., & Takumi, T. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvy022 · Cited by 131
Can Bayesian Theories of Autism Spectrum Disorder Help Improve Clinical Practice?
Haker, H., Schneebeli, M., & Stephan, K. E. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00107 · Cited by 130
“This strong genetic influence has been further elucidated by recent genome-wide analyses of large populations that suggested two different types of genetic contributions to the risk of ASD (16): while some rare de novo mutations can be sufficient to convey risk, in other cases, a wide range (>1000) of common single nu…”
BackgroundAging is associated with a systemic length-associated transcriptome imbalance
Stoeger, T., Grant, R. A., McQuattie-Pimentel, A. C., Anekalla, K. R., Liu, S. S., Tejedor-Navarro, H., Singer, B. D., Abdala-Valencia, H., Schwake, M., Tetreault, M.-P., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00317-6 · Cited by 119
Sestan, N., & State, M. W. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.015 · Cited by 127
Stephenson, J. R., Wang, X., Perfitt, T. L., Parrish, W. P., Shonesy, B. C., Marks, C. R., Mortlock, D. P., Nakagawa, T., Sutcliffe, J. S., & Colbran, R. J. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2068-16.2017 · Cited by 127
Davenport, E. C., Szulc, B. R., Drew, J., Taylor, J., Morgan, T., Higgs, N. F., López-Doménech, G., & Kittler, J. T. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.092 · Cited by 125
“…mutations and copy number variations (CNVs) (deletions and duplications) in functionally overlapping synaptic and neurodevelopmental gene sets linked to increased disease susceptibility (Bourgeron, 2015; Fromer et al., 2014; Iossifov et al., 2014; Marshall et al., 2017; De Rubeis et al., 2014).”
BackgroundHoogman, M., van Rooij, D., Klein, M., Boedhoe, P. S. W., Ilioska, I., Li, T., Patel, Y., Postema, M. C., Zhang‐James, Y., Anagnostou, E. A., et al. (2020) · Human Brain Mapping · doi:10.1002/hbm.25029 · Cited by 135
“Many of the genes hit by such rare risk variants are also likely to converge on biological processes (Bourgeron, 2015) that are shared by ASD and ADHD (and other neurodevelopmental disorders; Cristino et al., 2014; Schork et al., 2019).”
BackgroundNeurexins and neuropsychiatric disorders
Kasem, E. A., Kurihara, T., & Tabuchi, K. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.10.012 · Cited by 126
Pagan, C., Goubran-Botros, H., Delorme, R., Benabou, M., Lemière, N., Murray, K., Amsellem, F., Callebert, J., Chaste, P., Jamain, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02152-x · Cited by 112
Self-citationFunctional significance of rare neuroligin 1 variants found in autism
Nakanishi, M., Nomura, J., Ji, X., Tamada, K., Arai, T., Takahashi, E., Bućan, M., & Takumi, T. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006940 · Cited by 127
Christensen, N. R., Čalyševa, J., Fernandes, E. F. A., Lüchow, S., Clemmensen, L. S., Haugaard‐Kedström, L. M., & Strømgaard, K. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800143 · Cited by 123
Chen, H., Uddin, L. Q., Guo, X., Wang, J., Wang, R., Wang, X., Duan, X., & Chen, H. (2018) · Human Brain Mapping · doi:10.1002/hbm.24400 · Cited by 115
“At the genetic level, ASD is thought to be linked with more than 400 kinds of genetic mutations (Bourgeron, 2015).”
BackgroundNeuroinflammation in preterm babies and autism spectrum disorders
Bokobza, C., Steenwinckel, J. V., Mani, S., Mezger, V., Fleiss, B., & Gressèns, P. (2018) · Pediatric Research · doi:10.1038/s41390-018-0208-4 · Cited by 121
An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio
Sadybekov, A., Tian, C., Arnesano, C., Katritch, V., & Herring, B. E. (2017) · Nature Communications · doi:10.1038/s41467-017-00472-0 · Cited by 112
Darville, H., Poulet, A., Amsellem, F., Chatrousse, L., Pernelle, J., Boissart, C., Héron, D., Nava, C., Perrier, A. L., Jarrige, M., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.05.032 · Cited by 115
Self-citationOTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome
Uddin, M. J., Unda, B. K., Kwan, V., Holzapfel, N. T., White, S. H., Chalil, L., Woodbury‐Smith, M., Ho, K. S., Harward, E., Murtaza, N., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.01.006 · Cited by 115
“2 deletion and single-gene disorders such as fragile X syndrome (FXS) and tuberous sclerosis complex (TSC).(55,84) Thus, if OTUD7A is involved in protein turnover, particularly at the synapse, this would add to growing evidence that this is a common pathological mechanism for neurodevelopmental disorders involving def…”
BackgroundIntegrin activity in neuronal connectivity
Lilja, J., & Ivaska, J. (2018) · Journal of Cell Science · doi:10.1242/jcs.212803 · Cited by 107
“The pathophysiology of these disorders has been linked to dysregulation of processes that underlie proper establishment of neural circuits, including neurite outgrowth, guidance and targeting, as well as synaptogenesis and synaptic plasticity (Berretta, 2012; Bourgeron, 2015; Gejman et al., 2010; Joensuu et al., 2018;…”
BackgroundLoss of Sfpq Causes Long-Gene Transcriptopathy in the Brain
Takeuchi, A., Iida, K., Tsubota, T., Hosokawa, M., Denawa, M., Brown, J. B., Ninomiya, K., Ito, M., Kimura, H., Abe, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.141 · Cited by 102
“Genetic studies of ASD and schizophrenia (Geschwind, 2011; Veltman and Brunner, 2012) have revealed that their candidate genes are exceptionally long and encode synaptic scaffolding proteins, receptors, and cell adhesion molecules (Bourgeron, 2015).”
BackgroundPark, B., Hong, S., Valk, S. L., Paquola, C., Benkarim, O. M., Bethlehem, R. A. I., Martino, A. D., Milham, M. P., Gozzi, A., Yeo, B. T. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21732-0 · Cited by 125
Waterhouse, L., London, E., & Gillberg, C. (2016) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-016-0085-x · Cited by 91
The Genetics of Autism Spectrum Disorders
Huguet, G., Benabou, M., & Bourgeron, T. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-27069-2_11 · Cited by 125
Self-citationGuo, D., Peng, Y., Wang, L., Sun, X., Wang, X., Liang, C., Yang, X., Li, S., Xu, J., Ye, W.-C., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0472-7 · Cited by 109
“ASD exhibits a strong genetic basis, and increasing evidence from inherited and de novo gene variations suggests a notable convergence on synapse pathophysiology in ASD, particularly dysfunction of excitatory synaptic transmission 1, 2 .”
Amal, H., Barak, B., Bhat, V., Gong, G., Joughin, B. A., Wang, X., Wishnok, J. S., Feng, G., & Tannenbaum, S. R. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0113-6 · Cited by 101
Complement System in Brain Architecture and Neurodevelopmental Disorders
Magdalon, J., Mansur, F., Silva, A. L. T. E., de Goes, V. A., Reiner, O., & Sertie, A. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00023 · Cited by 110
“Recent molecular genetic studies have identified a specific cause for ASD in almost 30% of the cases, while in the remaining cases the underlying pathogenic mechanisms may involve complex genetic and environmental risk factors (Bourgeron, 2015).”
BackgroundConnor, S. A., Ammendrup-Johnsen, I., Chan, A. W., Kishimoto, Y., Murayama, C., Kurihara, N., Tada, A., Ge, Y., Lu, H., Yan, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.016 · Cited by 100
“Although there is considerable phenotypic and genetic heterogeneity, a major underlying pathway has emerged affecting synaptic transmission (Bourgeron, 2015; Chen et al., 2015).”
BackgroundDeneault, E., Faheem, M., White, S. H., Rodrigues, D. C., Sun, S., Wei, W., Piekna, A., Thompson, T., Howe, J. L., Chalil, L., et al. (2019) · eLife · doi:10.7554/elife.40092 · Cited by 94
Fossati, M., Assendorp, N., Gemin, O., Colasse, S., Dingli, F., Arras, G., Loew, D., & Charrier, C. (2019) · Neuron · doi:10.1016/j.neuron.2019.09.027 · Cited by 96
“Hence, synaptic dysfunctions cause a wide range of neurodevelopmental and psychiatric disorders, such as epilepsy, autisms, or schizophrenia (Bourgeron, 2015; Mullins et al., 2016; Nelson and Valakh, 2015; Ting et al., 2012; Zoghbi and Bear, 2012).”
BackgroundMicroglia-mediated synaptic pruning as a key deficit in neurodevelopmental disorders: Hype or hope?
Mordelt, A., & de Witte, L. D. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102674 · Cited by 103
Cerebellar involvement in autism and ADHD
Bruchhage, M. M. K., Bucci, M. P., & Becker, E. B. E. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64189-2.00004-4 · Cited by 110
PAK2 Haploinsufficiency Results in Synaptic Cytoskeleton Impairment and Autism-Related Behavior
Wang, Y., Zeng, C., Li, J., Zhou, Z., Ju, X., Xia, S., Li, Y., Liu, A., Teng, H., Zhang, K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.061 · Cited by 101
Tartaglione, A. M., Villani, A., Ajmone-Cat, M. A., Minghetti, L., Ricceri, L., Pazienza, V., De Simone, R., & Calamandrei, G. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02149-9 · Cited by 91
“Dysregulation of BDNF and its relative signaling pathway has been involved in ASD phenotype [44, 45], as well as in altered developmental pruning in multiple brain regions [46, 47].”
BackgroundVasa, R. A., Mostofsky, S. H., & Ewen, J. B. (2016) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2016.02.003 · Cited by 97
“impaired synapses), computational or information transmission characteristics (certain bandwidth and signal-to-noise ratio) (40).”
BackgroundP-cresol Alters Brain Dopamine Metabolism and Exacerbates Autism-Like Behaviors in the BTBR Mouse
Pascucci, T., Colamartino, M., Fiori, E., Sacco, R., Coviello, A., Ventura, R., Puglisi-Allegra, S., Turriziani, L., & Persico, A. M. (2020) · Brain Sciences · doi:10.3390/brainsci10040233 · Cited by 92
“contribute to the pathogenesis of ASD [5,6].”
Allen, M., Huang, B. S., Notaras, M. J., Lodhi, A., Barrio-Alonso, E., Lituma, P. J., Wolujewicz, P., Witztum, J., Longo, F., Chen, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01486-x · Cited by 88
“Likewise, astrocytes have been implicated in the formation of new memories through modulating LTP [21], and experimental manipulations of LTP can induce behavioral impairments associated with ASD [74, 75].”
Background
Metadata
- Authors
- Bourgeron, T.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Bourgeron, Thomas
- Venue
- Nature Reviews Neuroscience
- Published
- 2015-08-20
- Volume
- 16
- Issue
- 9
- Pages
- 551-563
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W1168911763
- Cited by
- 975
- References
- 178
- Citations by year
- 2026: 83 · 2025: 68 · 2024: 67 · 2023: 90 · 2022: 93 · 2021: 109 · 2020: 108 · 2019: 96 · 2018: 101 · 2017: 90 · 2016: 62 · 2015: 6
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Simons Foundation
- Institut national de la recherche scientifique
- Agence Nationale de la Recherche (ANR-13-SAMA-0006)
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- autism spectrum disorder, genetic architecture, synaptic plasticity, synaptic homeostasis hypothesis, risk genes, synaptic scaffolding proteins, adhesion molecules, chromatin remodeling, actin cytoskeleton dynamics, neuronal connectivity, genetic buffering
- MeSH terms
- Brain, Child Development Disorders, Pervasive, Humans, Neuronal Plasticity, Synapses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.